Fresenius Medical Care Midwest 27th Street Branch in Milwaukee, Wisconsin - Dialysis Center

Fresenius Medical Care Midwest 27th Street Branch is a medicare approved dialysis facility center in Milwaukee, Wisconsin and it has 16 dialysis stations. It is located in Milwaukee county at 3120 S 27th St, Milwaukee, WI, 53215. You can reach out to the office of Fresenius Medical Care Midwest 27th Street Branch at (414) 643-1714. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Midwest 27th Street Branch has the following ownership type - Profit. It was first certified by medicare in March, 2007. The medicare id for this facility is 522573 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFresenius Medical Care Midwest 27th Street Branch
Location3120 S 27th St, Milwaukee, Wisconsin
No. of Dialysis Stations 16
Medicare ID522573
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


3120 S 27th St, Milwaukee, Wisconsin, 53215
(414) 643-1714

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Fresenius Medical Care Midwest 27th Street Branch from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1023354867
Organization NameFresenius Medical Care Midwest 27th Street Branch
Doing Business AsFresenius Medical Care Midwest Dialysis, Llc
Address3120 S 27th St Milwaukee, Wisconsin, 53215
Phone Number(414) 672-1006

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago


NPI Number1083735567
Organization NameMidwest Dialysis Center, Inc-27th Street Branch
Doing Business AsMidwest Dialysis Center, Inc
Address3120 S 27th St Milwaukee, Wisconsin, 53215
Phone Number(414) 672-1006

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data59
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL17

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center96
    Adult patient months included in Kt/V greater than or equal to 1.2851
    Percentage of adult patients getting regular hemodialysis at the center98
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Cell biologists identify new way for curing cancer and vessel diseases

    Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

    Omega-3 fatty acids ineffective for managing Crohn's disease

    An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

    American Football players face risk of future sleep breathing issues, study finds

    The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

    Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

    Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

    Researchers identify gene involved in building circuitry that relays signals via brain

    Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

    Read more Medical News

    › Verified 4 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center38
    Adult patient months included in Kt/V greater than or equal to 1.7313
    Percentage of adult patients getting regular peritoneal dialysis at the center97
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Cell biologists identify new way for curing cancer and vessel diseases

    Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

    Omega-3 fatty acids ineffective for managing Crohn's disease

    An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

    American Football players face risk of future sleep breathing issues, study finds

    The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

    Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

    Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

    Researchers identify gene involved in building circuitry that relays signals via brain

    Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

    Read more Medical News

    › Verified 4 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care Midwest 27th Street Branch with elevated calcium levels.

Patients with hypercalcemia134
Hypercalcemia patient months1199
Patients with Serumphosphor143
Patients with Serumphosphor less than 3.5 mg/dL5
Patients with Serumphosphor from 3.5 to 4.5 mg/dL20
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL30
Patients with Serumphosphor greater than 7 mg/dL17

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 72
Patient months included in arterial venous fistula and catheter summaries 582
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment66
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer10

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary97
Hospitalization Rate in facility246.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit376.5
Hospitalization Rate: Lower Confidence Limit165.7

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care Midwest 27th Street Branch were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility25.9 (As Expected)
Readmission Rate: Upper Confidence Limit37.6
Readmission Rate: Lower Confidence Limit16.1

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care Midwest 27th Street Branch get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.97 (As Expected)
SIR: Upper Confidence Limit3.51
SIR: Lower Confidence Limit1

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care Midwest 27th Street Branch's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 83
Transfusion Rate in facility28.3 (As Expected)
Transfusion Rate: Upper Confidence Limit75.3
Transfusion Rate: Lower Confidence Limit12

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care Midwest 27th Street Branch lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary548
Mortality Rate in facility18.8 (As Expected)
Mortality Rate: Upper Confidence Limit23.9
Mortality Rate: Lower Confidence Limit14.6

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago


Dialysis Facility in Milwaukee, WI

Davita - Wisconsin Ave
Location: 3801 W Wisconsin Ave, Milwaukee, Wisconsin, 53208
Phone: (414) 937-8240
Fresenius Medical Care Midwest South
Location: 3267 S 16th St Suite 203, Milwaukee, Wisconsin, 53215
Phone: (414) 672-8230
Davita - Rivercenter Dr
Location: 117 N Jefferson St, Milwaukee, Wisconsin, 53202
Phone: (414) 225-3740
FMC Dialysis - Milwaukee
Location: 161 W Wisconsin Ave, Milwaukee, Wisconsin, 53203
Phone: (414) 224-7666
Fresenius Medical Care Midwest Dialysis, Llc
Location: 4021 N 52nd St, Milwaukee, Wisconsin, 53216
Phone: (414) 873-3600

News Archive

Cell biologists identify new way for curing cancer and vessel diseases

Cell biologists from the Lomonosov Moscow State University discovered a new way of regulating of cell motility - this discovery will make possible development of new drugs for curing onco- and vessel diseases.

Omega-3 fatty acids ineffective for managing Crohn's disease

An international study led by Dr. Brian Feagan of Robarts Research Institute at The University of Western Ontario in London, Canada has found that omega-3 fatty acids are ineffective for managing Crohn's disease.

American Football players face risk of future sleep breathing issues, study finds

The forthcoming study in the Journal of Sport Rehabilitation reveals that college football players undergo sleep apnea–a serious breathing problem during sleep often found in football players, and particularly in linemen.

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

Researchers identify gene involved in building circuitry that relays signals via brain

Using a powerful gene-hunting technique for the first time in mammalian brain cells, researchers at Johns Hopkins report they have identified a gene involved in building the circuitry that relays signals through the brain.

Read more Medical News

› Verified 4 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.